Vivimed Labs Limited Financial Ratios
VIVIMEDLAB · Healthcare · Current price ₹6.71
P/E ratio
-0.3x
P/B ratio
-0.2x
ROE
90.9%
ROCE
-91.6%
Debt / Equity
—
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -0.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | -0.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 90.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -91.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | — | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Vivimed Labs Limited's latest numbers.
Vivimed Labs Limited profitability
Vivimed Labs Limited generates a return on equity of 90.9% and a return on capital employed of -91.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of n/a and a P/E of -0.3x, Vivimed Labs Limited is conservatively financed. Our overall business-quality score for the company is 3.8 / 10.
Understand the ratios
More on Vivimed Labs Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.